Justeau G, Huchot E, Simonneau Y, Roa M, et al. Impact of KRAS G12C mutation in patients with advanced non-squamous non-small cell lung cancer treated with first-line pembrolizumab monotherapy. Lung Cancer 2022;174:45-49.
PMID: 36323057